According to IMARC Group’s latest report, titled “Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.’ the global breast lesion localization methods market size reached US$ 1,102.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,018.5 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028.
Breast lesion localization methods are a set of various techniques utilized for diagnosing abnormal changes in the breast lesions or breast tissues. Some commonly deployed procedures are radioactive seed localization (RSL), intraoperative ultrasound (IOUS), wire localization, radio-guided occult lesion localization (ROLL), magnetic resonance imaging (MRI), and ultrasound. These methods enable doctors to facilitate suitable treatment and surgery for the patients.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/breast-lesion-localization-methods-market/requestsample
Breast Lesion Localization Methods Market Trends:
The increasing prevalence of breast cancer, along with the escalating requirement of lumpectomy and surgical biopsy procedures is one of the key factors primarily driving the market growth. In addition to this, the rising investment and fundings in the research and development (R&D) activities for enhancing biomedical, imaging, surgical, and breast lesion localization procedures are propelling the market growth. Apart from this, the growing demand for cosmetic surgeries, especially breast enhancement, and the numerous initiatives undertaken by the regulatory bodies of various countries for strengthening the healthcare infrastructure are positively stimulating the market growth.
Breast Lesion Localization Methods Market 2023-2028 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global breast lesion localization methods market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Argon Medical Devices Inc.
- Becton Dickinson and Company
- Cook Group Incorporated
- CP Medical Inc. (Theragenics Corporation)
- Endomagnetics Ltd.
- Hologic Inc.
- IsoAid LLC
- IZI Medical Products (Landauer Inc)
- Laurane Medical LLC
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
- Merit Medical Systems Inc
- Sterylab S.r.l.
Key Market Segmentation:
The report has segmented the global breast lesion localization methods market on the basis of type, usage, end user and region
Breakup by Type:
- Wire Localization
- Radioisotope Localization
- Magnetic Tracers Localization
- Others
Breakup by Usage:
- Tumor Identification
- Sentinel Lymph Node IdentificationLumpectomy
Mastectomy
Breakup by End User:
- Hospitals
- Diagnostic Centres
- Oncology Clinics
- Ambulatory Surgical Centers
Breakup by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4890&flag=E
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
134 N 4th St
Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800